NCT03084965已完成不适用
Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,987
- 试验地点
- 1
- 主要终点
- Change in HbA1c
研究概览
简要总结
Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- — 至 99 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Outpatient equal to or more than 20 years of age.
- •T2DM patient initiated dapagliflozin after May 1st 2016 as a second line or third line oral anti-diabetic therapy, either as add-on or switching from one to another. Or initiating dapagliflozin as adjunctive therapy for T2DM subjects treated with insulin.
- •Completed follow-up of at least 6 months regardless of continuation on dapagliflozin therapy.
- •Will provide completed and signed written informed consents.
排除标准
- •Subjects with a history of SGLT2 inhibitor therapy other than dapagliflozin prior to Baseline.
- •Subjects with Type 1 diabetes.
- •Treatment with other investigational drugs concurrently during the retrospective data collection period.
结局指标
主要结局
Change in HbA1c
时间窗: 6 months
To assess the change from baseline (time to initiate dapagliflozin\*) in HbA1c at 6 months
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
The Japanese T2D study for evaluating Benefits Of a New first-line therapy with Dapagliflozin in consideration of improving QOD003924Type 2 Diabetes MellitusDiabetes Mellitus, Type 2JPRN-jRCTs051180165Ishii Hitoshi253
招募中
2 期
A single-site study of the effectiveness of Dapagliflozin for diabetic patients admitted to the intensive care unitMetabolic and Endocrine - DiabetesDiabetesACTRN12621001102864Austin Health40
已完成
不适用
Investigation of the Effect of Dapagliflozin on Body Composition and Diet in Japanese Patients with Type 2 Diabetes MellitusType 2 Diabetes mellitusJPRN-UMIN000019192Department of Medicine and Bioregulatory, Graduate School of Medical Sciences, Kyushu University60
已完成
3 期
Dapagliflozin DPPIV Inhibitor add-on StudyType 2 DiabetesNCT00984867AstraZeneca833
已完成
不适用
Effect of Dapagliflozin in patients with type 2 daibetes mellitusType 2 diabetes mellitusJPRN-UMIN000014922Iwasaki Naika Clinic50